Evaluation of neuromuscular symptoms in veterans of the Persian Gulf War

Neurology

Volumn 48, Issue 1, 1997, Pages 4-12

  Amato, Anthony A ^a,b   McVey, A ^a   Cha, C ^a   Matthews, E C ^a   Jackson, C E ^b   Kleingunther, R ^b   Worley, L ^b   Cornman, E ^a   Kagan Hallet, K ^c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTROMYOGRAM; HUMAN; MAJOR CLINICAL STUDY; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYALGIA; NEUROMUSCULAR DISEASE; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; WAR;

EID: 0031016307     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.4     Document Type: Article

References (65)

1. Institute of Medicine. Health consequences of service during the Persian Gulf War: initial findings and recommendations for immediate action. Washington, DC: National Academy Press, 1995.
2. Kiser KW, Joseph S, Moll M, Rankin JT. Unexplained illness among Persian Gulf war veterans in an Air National Guard unit: preliminary report, August 1990-March 1995. JAMA 1995;274:16-17 and MMWR Morb Mortal Wkly Rep 1995;44: 443-447.
3. Kiser KW, Joseph S, Moll M, Rankin JT. Unexplained illness among Persian Gulf war veterans in an Air National Guard unit: preliminary report, August 1990-March 1995. JAMA 1995;274:16-17 and MMWR Morb Mortal Wkly Rep 1995;44: 443-447.
4. Gunby P. Institute of Medicine calls for coordinated studies of Gulf War veterans' health complaints [news]. JAMA 1995;273: 444-445.
5. NIH Technology Assessment Workshop Panel. The Persian Gulf experience and health. JAMA 1994;272:391-396.
6. Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans. Arch Intern Med 1995; 155:262-268.
7. Baker MS, Strunk HK. Medical aspects of Persian Gulf operations: serious infectious and communicable diseases of the Persian Gulf and Saudi Arabian peninsula. Mil Med 1991;156: 385-390.
8. Gasser RA, Magill AJ, Oster CN, Tramont EC. The threat of infectious disease in Americans returning from Operation Desert Storm. N Engl J Med 1991;324:859-864.
9. Center for Disease Control. Viscerotropic leishmaniasis in persons returning from Operation Desert Storm, 1990-1991. JAMA 1992;267:1444-1446.
10. Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328:1383-1387.
11. Boyer MH. Visceral leishmaniasis in Desert Storm veterans [letter]. N Engl J Med 1993;329:1503-1504.
12. Mendell JR, Florence J. Manual muscle testing. Muscle Nerve 1990;13(Suppl):S16-S20.
13. Amato AA, Barohn RJ, Jackson CE, Pappert EJ, Sahenk Z, Kissel JT. Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology 1994;44:1516-1518.
14. Griggs RC, Mendell JR, Miller RG. Evaluation and treatment of myopathies. Philadelphia: FA Davis, 1995:252.
15. Howard JF Jr, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurol Clin 1994;12:305-330.
16. Buchthal F. An introduction to electromyography. Copenhagen: Scandinavian University Books, 1957.
17. Trontelj JV, Stalberg EV. Jitter measurement by axonal microstimulation: guidelines and technical notes. Electroencephalogr Clin Neurophysiol 1992;85:30-37.
18. Trontelj JV, Stalberg EV, Mihelin M, et al. Jitter of the stimulated motor axon. Muscle Nerve 1992;15:449-454.
19. Jabre JF, Chirico-Post J, Weiner M. Stimulation SFEMG in myasthenia gravis. Muscle Nerve 1989;12:38-42.
20. Trontelj JV, Mihelin M, Fernandez M, Stalberg EV. Axonal stimulation for end-plate jitter studies. J Neurol Neurosurg Psychiatry 1986;49:677-685.
21. Banker BQ, Engel AG. Basic reactions of muscle. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw Hill, 1994:855-856.
22. Fardeau M, Tomé FMS. Congenital myopathies. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw Hill, 1994:1516-1519.
23. Griggs RC, Mendell JR, Miller RG. Evaluation and treatment of myopathies. Philadelphia: FA Davis Company, 1995:233-236.
24. Griggs RC, Mendell JR, Miller RG. Evaluation and treatment of myopathies. Philadelphia: FA Davis Company, 1995:392-394.
25. Wong ET, Cobb C, Umehara MK, et al. Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol 1983;79:582-586.
26. Black HR, Quallich H, Gareleck CB. Racial differences in serum creatine kinase levels. Am J Med 1986;81:479-487.
27. Harris EK, Wong ET, Shaw ST. Statistical criteria for separate reference intervals: race and gender groups in creatine kinase. Clin Chem 1991;37:1580-1582.
28. Odor DL, Patel AN, Pearse LA. Familial hypokalemic periodic paralysis with permanent myopathy. J Neuropathol Exp Neurol 1967;26:98-114.
29. Engel WK, Bishop DW, Cunningham GG. Tubular aggregates in Type 2 muscle fibers: ultrastructural and histochemical correlation. J Ultrastruct Res 1970;31:507-525.
30. Engel AG, Lambert EH, Mulder DM, et al. Investigation of 3 cases of a newly recognized familial, congenital myasthenic syndrome [abstract], Ann Neurol 1979;6:146-147.
31. Dobkin BH, Verity MA. Familial neuromuscular disease with type 1 fiber hypoplasia, tubular aggregates, cardiomyopathy, and myasthenic features. Neurology 1978;28:1135-1140.
32. Morgan-Hughs JA, Lecky BRF, Landon DN, Murray NMF. Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates: a newly recognized receptor defect. Brain 1981;104:279-295.
33. deGroot JG, Arts WF. Familial myopathy with tubular aggregates. J Neurol 1982;227:35-44.
34. Rohkamm R, Boxler K, Ricker K, Jerusalem F. A dominantly inherited myopathy with tubular aggregates. Neurology 1983; 33:331-336.
35. Pierobon-Bormioli S, Armani M, Ringel S. Familial neuromuscular disease with tubular aggregates. Muscle Nerve 1985;8: 291-298.
36. Schiaffino S, Severin E, Cantini M, Sartore S. Tubular aggregates induced by anoxia in isolated rat skeletal muscle. Lab Invest 1977;37:223-228.
37. Chui LA, Neustein H, Munsat T. Tubular aggregates in subclinical alcoholic myopathy. Neurology 1975;25:405-412.
38. Del Villar Negro A, Merino Angulo J, Rivera Pomar JM, Aguirre Errasti C. Tubular aggregates in skeletal muscle of chronic alcoholic patients. Acta Neuropathol 1982;56:250-254.
39. Fardeau M, Tomé FMS, Simon P. Muscle and nerve changes induced by perhexiline in man and mice. Muscle Nerve 1979; 2:24-36.
40. Duchen LW. Changes in the electron microscopic structure of slow and fast muscle fibers of the mouse after local injection of botulinum toxin. J Neurol Sci 1971;14:61-74.
41. Duchen LW. The local effects of tetanus toxin on the electron microscopic structure of skeletal muscle fibers of the mouse. J Neurol Sci 1973;19:169-177.
42. Engel AG, Lambert EH, Santa T. Study of long-term anticholinesterase therapy: effects on neuromuscular transmission and on motor-end plate fine structure. Neurology 1973;23: 1273-1281.
43. Rosenberg NL, Neville HE, Ringel SP. Tubular aggregates: their association with neuromuscular diseases, including the syndrome of myalgias/cramps. Arch Neurol 1985;42:973-976.
44. Niakan E, Harati Y, Danon MJ. Tubular aggregates: their association with myalgia. J Neurol Neurosurg Psychiatry 1985-48:882-886.
45. Lazaro RP, Fenichel GM, Kilroy AW, Saito A, Fleisher S. Cramps, muscle pain, and tubular aggregates. Arch Neurol 1980;37:715-717.
46. Salvieti G, Pierobon-Bormioli S, Betto R, et al. Tubular aggregates: sarcoplasmic reticulum origin, calcium storage ability, and functional implications. Muscle Nerve 1985;8:299-306.
47. Martin DE, Mather K, Swash M, Gray AB. Expression of heat shock protein epitopes in tubular aggregates. Muscle Nerve 1991;14:219-225.
48. Mills KR, Edwards RHT. Investigative strategies for muscle pain. J Neurol Sci 1983;58:73-88.
49. Bengtsson A, Henriksson K-G, Larsson J. Muscle biopsy in primary fibromyalgia. Scand J Rheumatol 1986;15:1-6.
50. Pourmand R. The value of muscle biopsy in the evaluation of myopathy [abstract]. Muscle Nerve 1995;18:1053.
51. Ward MD, Forbes MS, Johns TR. Neostigmine methylsulfate: does it have a chronic effect as well as a transient one? Arch Neurol 1975;32:808-814.
52. Griggs RC, Mendell JR, Miller RG. Evaluation and treatment of myopathies. Philadelphia: FA Davis Company, 1995:389-407.
53. Bohr T. Problems with myofascial pain syndrome and fibromyalgia syndrome. Neurology 1996;46:593-597.
54. Yunus M, Kalyan-Raman U, Kaylan-Raman K, et al. Pathologic changes in muscle in primary fibromyalgia syndrome. Am J Med 1986;81(suppl 3A):38-42.
55. Yunus M, Kalyan-Raman U. Muscle biopsy findings in primary fibromyalgia and other forms of non-articular rheumatism. Rheum Dis Clin North Am 1989;15:115-134.
56. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 1993;5:199-208.
57. Komaroff AL, Goldenberg D. The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research. J Rheumatol 1989;16(suppl 19):23-27.
58. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994:445-469.
59. Bleich A, Dycian A, Koslowsky M, Solomaon Z, Weiner M. Psychiatric implications of missile attacks on a civilian population: Israeli lessons from the Persian Gulf War. JAMA 1992; 268:613-615.
60. Perconte ST, Wilson AT, Pontius EB, Dietrick AL, Spiro KJ. Psychological and war stress symptoms among deployed and non-deployed reservists following the Persian Gulf War. Mil Med 1993;8:516-521.
61. McDuff DR, Johnson JL. Classification and characteristics of army stress casualties during Operation Desert Storm. Hosp Community Psychiatry 1992;43:812-815.
62. Labbate LA, Snow MP. Posttraumatic stress symptoms among soldiers exposed to combat in the Persian Gulf. Hosp Community Psychiatry 1992;43:831-833.
63. Culclasure TF, Enzenauer RJ, West SG. Post-traumatic stress disorder presenting as fibromyalgia. Am J Med 1993;94:548-549.
64. Jamal GA, Hansen S, Apartopoulos F, Peden A. The "Gulf War syndrome." Is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiatry 1996;60:441-449.
65. Jamal GA, Weir AI, Hansen S, Ballantyne JP. Myotonic dystrophy. A reassessment by conventional and more recently introduced neurophysiological techniques. Brain 1986;109: 1279-1296.